The prognosis for ALL is poor and therapy has not changed for a decade. The drug inotuzumab ozogamicin now holds promise to change that outlook and improve outcomes.
The good news about chronic thromboembolic pulmonary hypertension (CTEPH)? Surgery is curative in over 90 percent of cases. The bad news? Physicians need to get a lot better at spotting it.
As recent research shows the utility of botulinum toxin for severe cases of cerebral palsy, it’s more important than ever to use ultrasound for optimal injection guidance in the pediatric population.
Analysis of the H1N1 pandemic of 2009-2010 finds that reporting outcomes from a relatively small number of patients from specific regions may lead to biased estimates of outcomes on a global scale.
Nurse-led research study focused on determining if management of systolic blood pressure during long transports would impact patient outcomes.
Learn about featured digestive disease clinical trials currently enrolling in Cleveland and Florida.
Retrievable inferior vena cava filters continue to be left in many patients long after the risk of embolism has passed. A vascular medicine specialist shares advice on how to minimize such oversights.
For the first time, a study has established previous external beam radiation therapy as an independent risk factor for all-cause and cardiovascular mortality after percutaneous coronary intervention.
U.S. News & World Report gives Cleveland Clinic Children’s the “thumbs up” in 9 specialties
At Cleveland Clinic, we’re using alternate methods of teaching surgical principles to our Ob/Gyn residents and providing procedural experience outside the clinical setting.